Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly LLY revealed 22 unusual trades.
Delving into the details, we found 31% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $79,790, and 19 were calls, valued at $3,152,686.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $240.0 to $1180.0 for Eli Lilly over the last 3 months.
Volume & Open Interest Development
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Eli Lilly's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Eli Lilly's significant trades, within a strike price range of $240.0 to $1180.0, over the past month.
Eli Lilly Option Activity Analysis: Last 30 Days
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BEARISH | 12/19/25 | $700.0 | $690.0 | $694.0 | $240.00 | $1.3M | 17 | 0 |
| LLY | CALL | SWEEP | BULLISH | 11/15/24 | $112.0 | $108.65 | $112.0 | $840.00 | $560.0K | 2.2K | 50 |
| LLY | CALL | SWEEP | BULLISH | 09/13/24 | $7.0 | $6.0 | $6.51 | $925.00 | $333.3K | 359 | 708 |
| LLY | CALL | TRADE | BEARISH | 09/13/24 | $8.4 | $6.8 | $6.8 | $925.00 | $102.0K | 359 | 858 |
| LLY | CALL | SWEEP | BULLISH | 09/13/24 | $3.2 | $2.7 | $3.19 | $935.00 | $79.6K | 530 | 70 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Where Is Eli Lilly Standing Right Now?
- Currently trading with a volume of 233,725, the LLY's price is up by 0.08%, now at $921.59.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 49 days.
Professional Analyst Ratings for Eli Lilly
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $991.2.
- An analyst from Berenberg persists with their Buy rating on Eli Lilly, maintaining a target price of $1050.
- Consistent in their evaluation, an analyst from Guggenheim keeps a Buy rating on Eli Lilly with a target price of $1030.
- In a cautious move, an analyst from Morgan Stanley downgraded its rating to Overweight, setting a price target of $1106.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $885.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
